Drug
Stavudine clinical trials
Also written d4T.
- studies test it
- 52
- open now
- 0
- in phase 3
- 15
- first study started
- 1995
How studies write it
Studies that test it under each name
Studies by the year they started
29 studies that test it; most in 1999 (4)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1996 | 1 |
| 1997 | 3 |
| 1998 | 1 |
| 1999 | 4 |
| 2000 | 3 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2012 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 16
- Phase 3
- 15
- Phase 4
- 8
- No phase
- 8
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 27 · Other 25
Bristol-Myers Squibb (14) · National Institute of Allergy and Infectious Diseases (NIAID) (12) · Merck Sharp & Dohme LLC (3) · Dupont Merck (2) · Triangle Pharmaceuticals (2) · Willem Daniel Francois Venter (1) · SEARCH Research Foundation (1) · National Institutes of Health Clinical Center (CC) (1)
Often tested with
Tested in the same studies.
Lamivudine (23) · Didanosine (18) · Zidovudine (12) · Nevirapine (10) · Efavirenz (9) · Indinavir (8) · Hydroxyurea (7) · Nelfinavir (6)
Studies
Open first, then newest update. How each study uses Stavudine is read from its arms, and is right about nine times in ten.
Testing it · 52
- Preventing Sexual Transmission of HIV With Anti-HIV DrugsCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00074581Written as Stavudine
- A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV InfectionCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000789Written as Stavudine
- Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected ChildrenCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000851Written as Stavudine
- Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or DidanosineCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000838Written as Stavudine
- Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai ChildrenCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00312091Written as Stavudine
- Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIVCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000940Written as Stavudine
- A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their InfantsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000878Written as Stavudine
- Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected ChildrenCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT00000901Written as Stavudine
- Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, KenyaTerminatedPhase 3University of WashingtonNCT00427297Written as d4T/3TC/NVP (stavudine/lamivudine/nevirapine)
- Dose Optimisation of Stavudine for the Treatment of HIV InfectionCompletedPhase 3Willem Daniel Francois VenterNCT02670772Written as Stavudine
- A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVPCompletedPhase 3SEARCH Research FoundationNCT00669487Written as AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP
- A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV InfectionCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00006154Written as Stavudine
- Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced SubjectsCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00000882Written as Stavudine
- Antiretroviral Therapy for Advanced HIV Disease in South AfricaCompletedPhase 4National Institutes of Health Clinical Center (CC)NCT00342355Written as Stavudine
- Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected PatientsTerminatedPhase 4University of Witwatersrand, South AfricaNCT01601899Written as Stavudine
- A Study of Stavudine in HIV-Infected Patients Who Have Not Had Success With Other Anti-HIV DrugsCompletedNot applicableBristol-Myers SquibbNCT00002308Written as Stavudine
- A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected PatientsCompletedNot applicableBristol-Myers SquibbNCT00002307Written as Stavudine
- A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia ComplexCompletedPhase 3Bristol-Myers SquibbNCT00002246Written as Stavudine
- Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected PatientsCompletedPhase 3Bristol-Myers SquibbNCT00005918Written as Stavudine
- The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken ZidovudineCompletedPhase 3Bristol-Myers SquibbNCT00002371Written as Stavudine
See all 52 studies that test Stavudine →
Given in every arm · 4 — Stavudine is usual care beside what is tested
- Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without TipranavirCompletedPhase 2Boehringer IngelheimNCT02249130Written as Stavudine (d4T)
- Anti-HIV Treatment Interruptions in HIV Infected Adults in South AfricaCompletedNot applicableThe Wistar InstituteNCT00100646Written as Stavudine
- Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African CommunitiesCompletedNot applicableCIPRA SANCT00255840Written as Stavudine
- ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected SubjectsCompletedPhase 1/2AbbottNCT00004578Written as Stavudine
As the comparator · 4 — what is tested is compared with Stavudine
- Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected ChildrenCompletedPhase 3Gilead SciencesNCT00528957Written as Stavudine
- Treatment Options for Protease Inhibitor-exposed ChildrenCompletedPhase 3Columbia UniversityNCT01146873Written as Stavudine (D4T)
- Intermittent ART in Primary HIV InfectionCompletedPhase 4Juan A. ArnaizNCT02300623Written as Antiretroviral therapy alone
- Triomune Bioequivalence With InnovatorsCompletedPhase 4Makerere UniversityNCT01025830Written as Zerit/Epivir/Viramune
Codes
What other systems call Stavudine · ClinicalTrials.gg INT008630
- MeSH (NLM) D018119StavudineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) BO9LE4QFZFSTAVUDINEConfirmed FDA, NLM, Wikidata
- RxNorm 59763Confirmed FDA, Wikidata
- Wikidata Q423984stavudineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1428StavudineOne source FDA
- DrugBank DB00649One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D018119 | Stavudine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | BO9LE4QFZF | STAVUDINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 59763 | — | Confirmed FDA, Wikidata |
| Wikidata | Q423984 | stavudine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1428 | Stavudine | One source FDA |
| DrugBank | DB00649 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.